For patients who experience recurrent strokes/transient ischemic attacks despite maximal medical management, endovascular treatment effectively deals with these problems. Compared with percutaneous ...
163.com Background Endovascular therapy administered within 24 hours has been shown to improve outcomes for patients with acute ischemic stroke with large infarction, but the data on its ...
Zacks.com on MSN19d
STXS Stock Gains Following the First Order for its GenesisXStereotaxis, Inc. STXS, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, recently received its first order for the latest generation robotic system, ...
Aims: The study aims to investigate the impact of key parameters of pulsed field ablation (PFA) on lesion depth, including voltage (V), pulse width (PW), number of pulses (P), and ablation number (N), ...
Left atrial appendage closure (LAAC) was compared with oral anticoagulation therapy (OAC) for stroke protection in post-ablation patients with atrial fibrillation (AFib) in the OPTION trial. Among ...
Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that it received European CE Mark approval for the MAGiC ablation catheter.
The Magic ablation catheter ... to make robotics broadly impactful and beneficial in electrophysiology and endovascular surgery.” ...
LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback